Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Antiviral Therapy|January 18, 2005
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapiesVincent Soriano, Ivana Maida, Marina Núñez, et al.
AIDS (London, England)|February 20, 2020
Hospital admissions in individuals with HTLV-1 infection in SpainJosé-Manuel Ramos, Carmen de Mendoza, Antonio Aguilera, et al.
Expert Opinion on Drug Safety|April 25, 2023
Safety considerations in the management of hepatitis C and HIV co-infectionVicente Soriano, Víctor Moreno-Torres, Ana Treviño, et al.
Antiviral Therapy|March 30, 2017
Decline and changing profile of hepatitis delta among injection drug users in SpainAntonio Aguilera, Rocio Trastoy, Pablo Barreiro, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2011
Directly acting antivirals against hepatitis C virusVincent Soriano, Eugenia Vispo, Eva Poveda, et al.
AIDS Reviews|August 19, 2007
Update on the treatment of chronic hepatitis C in HIV-infected patientsVincent Soriano, Pablo Barreiro, Luz Martin-Carbonero, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 29, 2017
Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis CVicente Soriano, Laura Benítez-Gutiérrez, Ana Arias, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2014
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patientsJosé Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, et al.
Antiviral Therapy|June 26, 2015
Hepatitis C cure with antiviral therapy--benefits beyond the liverVincent Soriano, Pablo Labarga, José V Fernandez-Montero, et al.
AIDS Reviews|January 24, 2022
Oral antivirals for the prevention and treatment of SARS-CoV-2 infectionVicente Soriano, Carmen de-Mendoza, Benson Edagwa, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Antiviral Therapy|January 18, 2005
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapiesVincent Soriano, Ivana Maida, Marina Núñez, et al.
AIDS (London, England)|February 20, 2020
Hospital admissions in individuals with HTLV-1 infection in SpainJosé-Manuel Ramos, Carmen de Mendoza, Antonio Aguilera, et al.
Expert Opinion on Drug Safety|April 25, 2023
Safety considerations in the management of hepatitis C and HIV co-infectionVicente Soriano, Víctor Moreno-Torres, Ana Treviño, et al.
Antiviral Therapy|March 30, 2017
Decline and changing profile of hepatitis delta among injection drug users in SpainAntonio Aguilera, Rocio Trastoy, Pablo Barreiro, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2011
Directly acting antivirals against hepatitis C virusVincent Soriano, Eugenia Vispo, Eva Poveda, et al.
AIDS Reviews|August 19, 2007
Update on the treatment of chronic hepatitis C in HIV-infected patientsVincent Soriano, Pablo Barreiro, Luz Martin-Carbonero, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 29, 2017
Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis CVicente Soriano, Laura Benítez-Gutiérrez, Ana Arias, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2014
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patientsJosé Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, et al.
Antiviral Therapy|June 26, 2015
Hepatitis C cure with antiviral therapy--benefits beyond the liverVincent Soriano, Pablo Labarga, José V Fernandez-Montero, et al.
AIDS Reviews|January 24, 2022
Oral antivirals for the prevention and treatment of SARS-CoV-2 infectionVicente Soriano, Carmen de-Mendoza, Benson Edagwa, et al.
Pageof 22